Similarly, Hyeongjwa et al. proposed targeting DEAD-box RNA helicase 3X (DDX3X) and ADAR1 triggers antitumor immunity through dsRNA-mediated endogenous tumor type I interferon response117. The gene discussed is ADAR; the disease is neoplasm.